$AIMD
Ainos, Inc.

2018 Q3 Form 10-Q Financial Statement

#000101476318000019 Filed on November 14, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2017 Q4 2017 Q3
Revenue $14.91K $0.00
YoY Change
Cost Of Revenue $16.79K $0.00
YoY Change
Gross Profit -$1.883K $0.00
YoY Change
Gross Profit Margin -12.63%
Selling, General & Admin $307.0K $180.0K $230.9K
YoY Change 32.96% -21.74% 29.36%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $307.0K $180.0K $230.9K
YoY Change 32.96% -21.74% 29.36%
Operating Profit -$308.8K -$180.0K -$230.9K
YoY Change 33.77% -21.74% 29.36%
Interest Expense $1.191K -$30.00K $1.929K
YoY Change -38.26% 141.73%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$310.0K -$210.0K -$230.0K
YoY Change 34.78% -8.7% 27.78%
Income Tax
% Of Pretax Income
Net Earnings -$310.0K -$210.0K -$232.8K
YoY Change 33.18% -8.7% 29.86%
Net Earnings / Revenue -2079.68%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.13 -$0.14 -$0.15
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q3 2017 Q4 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.140M $1.980M $150.0K
YoY Change 660.0% 1423.08% -16.67%
Cash & Equivalents $1.143M $2.038M $145.0K
Short-Term Investments
Other Short-Term Assets $50.00K $80.00K $70.00K
YoY Change -28.57% -27.27% -36.36%
Inventory $22.67K
Prepaid Expenses
Receivables $10.00K
Other Receivables $0.00
Total Short-Term Assets $1.196M $2.084M $212.3K
YoY Change 463.37% 694.38% -24.57%
LONG-TERM ASSETS
Property, Plant & Equipment $19.00K $27.00K $31.30K
YoY Change -39.31% -38.94% -31.76%
Goodwill $133.4K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $320.9K $209.4K $210.5K
YoY Change 52.42% 4.55% 31.18%
TOTAL ASSETS
Total Short-Term Assets $1.196M $2.084M $212.3K
Total Long-Term Assets $320.9K $209.4K $210.5K
Total Assets $1.517M $2.294M $422.8K
YoY Change 258.78% 395.78% -4.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $140.0K $160.0K $180.0K
YoY Change -22.22% -5.88% 38.46%
Accrued Expenses $10.00K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $510.0K $890.0K $890.0K
YoY Change -42.7% 12.66% 12.66%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $707.3K $1.823M $1.401M
YoY Change -49.53% 43.26% 50.81%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $707.3K $1.823M $1.401M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $707.3K $1.823M $1.401M
YoY Change -49.53% 43.26% 50.81%
SHAREHOLDERS EQUITY
Retained Earnings -$2.702M -$1.884M -$1.675M
YoY Change 61.3% 48.74% 62.07%
Common Stock $373.0K $231.6K $230.8K
YoY Change 61.62% 5.66% 7.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $809.7K $470.8K -$978.6K
YoY Change
Total Liabilities & Shareholders Equity $1.517M $2.294M $422.8K
YoY Change 258.78% 395.78% -4.33%

Cashflow Statement

Concept 2018 Q3 2017 Q4 2017 Q3
OPERATING ACTIVITIES
Net Income -$310.0K -$210.0K -$232.8K
YoY Change 33.18% -8.7% 29.86%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$310.0K -$350.0K -$30.00K
YoY Change 933.33% 288.89% -70.0%
INVESTING ACTIVITIES
Capital Expenditures $10.00K $10.00K $10.00K
YoY Change 0.0% -80.0% -66.67%
Acquisitions
YoY Change
Other Investing Activities $60.00K
YoY Change
Cash From Investing Activities $60.00K -$10.00K -$10.00K
YoY Change -700.0% -80.0% -66.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 2.200M 120.0K
YoY Change -100.0% 2100.0%
NET CHANGE
Cash From Operating Activities -310.0K -350.0K -30.00K
Cash From Investing Activities 60.00K -10.00K -10.00K
Cash From Financing Activities 0.000 2.200M 120.0K
Net Change In Cash -250.0K 1.840M 80.00K
YoY Change -412.5% -4700.0% -161.54%
FREE CASH FLOW
Cash From Operating Activities -$310.0K -$350.0K -$30.00K
Capital Expenditures $10.00K $10.00K $10.00K
Free Cash Flow -$320.0K -$360.0K -$40.00K
YoY Change 700.0% 157.14% -69.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2016Q1 amar Amount Of Private Placement
AmountOfPrivatePlacement
937500
CY2016Q3 amar Amount Of Private Placement
AmountOfPrivatePlacement
1875000
CY2017Q4 amar Amount Of Private Placement
AmountOfPrivatePlacement
2812500
CY2018Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
CY2017Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
58135
CY2018Q3 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
56225
CY2017Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
777258
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2018Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1865312
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P5Y
CY2018Q3 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
168417
CY2018Q3 amar Common Stock Shares Outstanding And Reserved
CommonStockSharesOutstandingAndReserved
45968528
amar Dividends Payable Reversed
DividendsPayableReversed
34277
amar Dividends Payable Reversed
DividendsPayableReversed
CY2017Q4 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
886481
CY2018Q3 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
513356
amar Proceeds From Convertible Notes Payable Related Party Debt
ProceedsFromConvertibleNotesPayableRelatedPartyDebt
amar Proceeds From Convertible Notes Payable Related Party Debt
ProceedsFromConvertibleNotesPayableRelatedPartyDebt
95000
amar Proceeds From Repayments Of Convertible Debt
ProceedsFromRepaymentsOfConvertibleDebt
-195000
amar Proceeds From Repayments Of Convertible Debt
ProceedsFromRepaymentsOfConvertibleDebt
amar Proceeds From The Acquisition Of Aei
ProceedsFromTheAcquisitionOfAEI
63414
amar Proceeds From The Acquisition Of Aei
ProceedsFromTheAcquisitionOfAEI
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1980015
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
134125
amar Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Discount Rate
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedDiscountRate
0.0296
CY2016Q1 amar Shares Authorized During Period Private Placement
SharesAuthorizedDuringPeriodPrivatePlacement
5000000
CY2016Q3 amar Shares Authorized During Period Private Placement
SharesAuthorizedDuringPeriodPrivatePlacement
10000000
CY2017Q4 amar Shares Authorized During Period Private Placement
SharesAuthorizedDuringPeriodPrivatePlacement
15000000
amar Stock Issued For Accrued Liabilities
StockIssuedForAccruedLiabilities
77250
amar Stock Issued For Accrued Liabilities
StockIssuedForAccruedLiabilities
amar Stock Issued For Acquisition Of Acts
StockIssuedForAcquisitionOfActs
152302
amar Stock Issued For Acquisition Of Acts
StockIssuedForAcquisitionOfActs
amar Stock Issued For Advances From Investors
StockIssuedForAdvancesFromInvestors
721033
amar Stock Issued For Advances From Investors
StockIssuedForAdvancesFromInvestors
amar Stock Issued For Previously Received Funds
StockIssuedForPreviouslyReceivedFunds
85791
amar Stock Issued For Previously Received Funds
StockIssuedForPreviouslyReceivedFunds
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
145029
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-836698
CY2018Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
137761
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
159300
CY2018Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
6727
CY2017Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
CY2018Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3139033
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2123205
CY2018Q3 us-gaap Assets
Assets
1517081
CY2017Q4 us-gaap Assets
Assets
2293834
CY2018Q3 us-gaap Assets Current
AssetsCurrent
1196218
CY2017Q4 us-gaap Assets Current
AssetsCurrent
2084451
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;"> <tr> <td style="width:27pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div></div></div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><div style="display: inline; font-weight: bold;">Basis of presentation.</div></div> </td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 27pt;"> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> </td> <td> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The accompanying financial statements, which should be read in conjunction with the audited financial statements and footnotes included in the Company's Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>as filed with the Securities and Exchange Commission on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 17, 2018, </div>have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, they do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> necessarily indicative of the results that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be expected for the full year ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018.</div></div> </td> </tr> </table></div>
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1143317
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10904
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37299276
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23156563
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37299276
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23156563
CY2018Q3 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
2827305
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
372993
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
231565
CY2018Q3 us-gaap Cost Of Revenue
CostOfRevenue
16791
CY2017Q3 us-gaap Cost Of Revenue
CostOfRevenue
us-gaap Cost Of Revenue
CostOfRevenue
60837
us-gaap Cost Of Revenue
CostOfRevenue
58801
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
178125
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
CY2017Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
182386
CY2018Q3 us-gaap Goodwill
Goodwill
133449
CY2017Q4 us-gaap Goodwill
Goodwill
CY2018Q3 us-gaap Gross Profit
GrossProfit
-1883
CY2017Q3 us-gaap Gross Profit
GrossProfit
us-gaap Gross Profit
GrossProfit
10911
us-gaap Gross Profit
GrossProfit
191701
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2018Q3 us-gaap Interest Expense
InterestExpense
1191
CY2017Q3 us-gaap Interest Expense
InterestExpense
1929
us-gaap Interest Expense
InterestExpense
3544
us-gaap Interest Expense
InterestExpense
7630
us-gaap Interest Paid Net
InterestPaidNet
us-gaap Interest Paid Net
InterestPaidNet
CY2018Q3 us-gaap Inventory Net
InventoryNet
CY2017Q4 us-gaap Inventory Net
InventoryNet
22666
CY2018Q3 us-gaap Liabilities
Liabilities
707342
CY2017Q4 us-gaap Liabilities
Liabilities
1823039
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1517081
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2293834
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
707342
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1823039
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-195000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
239375
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
55643
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39945
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-697341
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-188526
CY2018Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
CY2017Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-18321
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-310039
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-232804
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-834268
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-408751
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
306965
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
230875
us-gaap Operating Expenses
OperatingExpenses
859956
us-gaap Operating Expenses
OperatingExpenses
592822
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-308848
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-230875
us-gaap Operating Income Loss
OperatingIncomeLoss
-849045
us-gaap Operating Income Loss
OperatingIncomeLoss
-401121
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
46174
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23635
CY2017Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
50625
CY2017Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
93750
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
144375
CY2018Q3 us-gaap Profit Loss
ProfitLoss
-310039
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2858
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
39945
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4913
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q3 us-gaap Profit Loss
ProfitLoss
-232804
us-gaap Profit Loss
ProfitLoss
-852589
us-gaap Profit Loss
ProfitLoss
-408751
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18997
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26997
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2702287
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1883975
CY2018Q3 us-gaap Revenues
Revenues
14908
CY2017Q3 us-gaap Revenues
Revenues
us-gaap Revenues
Revenues
71748
us-gaap Revenues
Revenues
250502
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
306965
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35199804
CY2017Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
230875
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
859956
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
592822
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.76
CY2018Q3 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
539447
CY2018Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
809739
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
470795
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22789370
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34715330
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22500663
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.384
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.384
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y
us-gaap Stock Issued1
StockIssued1
us-gaap Stock Issued1
StockIssued1
10671

Files In Submission

Name View Source Status
0001014763-18-000019-index-headers.html Edgar Link pending
0001014763-18-000019-index.html Edgar Link pending
0001014763-18-000019.txt Edgar Link pending
0001014763-18-000019-xbrl.zip Edgar Link pending
amar-20180930.xml Edgar Link completed
amar-20180930.xsd Edgar Link pending
amar-20180930_cal.xml Edgar Link unprocessable
amar-20180930_def.xml Edgar Link unprocessable
amar-20180930_lab.xml Edgar Link unprocessable
amar-20180930_pre.xml Edgar Link unprocessable
exhibit31-1a_09302018.htm Edgar Link pending
exhibit31-1b_09302018.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-q_09302018.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending